Site of care dispensing programs are faced with numerous financial, patient access and accreditation challenges from pharmacy benefit managers. These challenges threaten site of care dispensing, which is vital to providing outstanding care for patients receiving oral oncolytics.
Casey Foster, Lead Consultant for VitalSource™ GPO’s Site of Care Dispensing Solutions, led a panel discussion with Ricky Newton of COA, Mike Reff of the National Community Oncology Dispensing Association (NCODA), and VitalSource™ GPO member Chris Kepinski, PharmD, Pharmacy Manager at Southern Oncology Specialists. In this enlightening discussion, the panel reviewed ways for stakeholders to collaborate on strategies for combating these financial pressures to preserve site of care dispensing for the future.
Ricky shared some of the work that COA is doing to help ensure “Fair and Reasonable” reimbursement for practices dispensing oral medication. In addition to their legal advocacy, COA is also lobbying for more permanent legislative changes at a national level. More information about their efforts and how practices can join in these efforts will be shared at an upcoming webinar, scheduled later this month.
Mike shared how NCODA’s Going Beyond the First Fill initiative is helping practices across the country gain access to specialty commercial networks that carve out refills to specialty pharmacies. Working with NCODA to gain access to these networks has helped practices not only improve patient access but also the improve the quality of care they are receiving.
Chris shared how his practice was able to successfully grow its oral dispensing operation by leveraging these advocacy groups and using tools provided by VitalSource™ GPO. As a result of this collaboration, Chris’ practice has been able to improve their reimbursement and has a better understanding of the revenue stream oral dispensing provides. Additionally, the visibility they’ve gained to their empirical data using VitalSource™ GPO’s analytics tools has allowed them to share data with private commercial insurers, which has resulted in increased access for patients.